APA (7th ed.) Citation

Raj, V., Venkataraman, B., Ojha, S. K., Almarzooqi, S., Subramanian, V. S., Al-Ramadi, B. K., . . . Subramanya, S. B. (2023). Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies. Molecules (Basel, Switzerland), 28(7), 2982. https://doi.org/10.3390/molecules28072982

Chicago Style (17th ed.) Citation

Raj, Vishnu, Balaji Venkataraman, Shreesh K. Ojha, Saeeda Almarzooqi, Veedamali S. Subramanian, Basel K. Al-Ramadi, Thomas E. Adrian, and Sandeep B. Subramanya. "Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies." Molecules (Basel, Switzerland) 28, no. 7 (2023): 2982. https://doi.org/10.3390/molecules28072982.

MLA (9th ed.) Citation

Raj, Vishnu, et al. "Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies." Molecules (Basel, Switzerland), vol. 28, no. 7, 2023, p. 2982, https://doi.org/10.3390/molecules28072982.